Activation and spatial redistribution of RNA splicing factors trigger hepatic regeneration.

IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Yachun An, Jiabei Lian, Wenjing Wei, Yunuo Mao, Longxin Qiao, Tingting Li, Ruijian Li, Shumin Li, Shigang Zhao, Xuena Chen, Han Zhao, Huili Hu
{"title":"Activation and spatial redistribution of RNA splicing factors trigger hepatic regeneration.","authors":"Yachun An, Jiabei Lian, Wenjing Wei, Yunuo Mao, Longxin Qiao, Tingting Li, Ruijian Li, Shumin Li, Shigang Zhao, Xuena Chen, Han Zhao, Huili Hu","doi":"10.1016/j.jcmgh.2025.101654","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Tissue injury with regenerative obstacle leads to liver failure and inevitable consequent hepatic diseases. Yet, precise spatial and molecular alterations to initiate liver regeneration remains unknown.</p><p><strong>Methods: </strong>We employ spatiotemporal sequencing of regenerating liver combined with high-throughput single-cell RNA sequencing of established hepatocyte organoids (Hep-Orgs) mimicking the regenerative start, elucidate that splicing factors (SFs) were key factors responsible for liver regeneration. Additionally, we verify the function of splicing factors in knockout mice models in vivo.</p><p><strong>Results: </strong>We observed that the up-regulation of SFs in regenerative zone of liver and pre-cycling or cycling hepatocytes subpopulation of Hep-Orgs. We demonstrated that the splicing inhibitors suppress liver regeneration by increasing ribosomal proteins. Moreover, we identified Hnrnpu as the key SF for liver regeneration benefit to preventing chronic liver disease like metabolic dysfunction-associated steatotic liver disease (MASLD) CONCLUSIONS: The spatial remodeling of upregulated RNA splicing factors drives the first regenerative wave from the periportal zone. The reprogrammed subpopulations defined by highly expressed SFs represent original repopulating hepatocytes. Inhibiting RNA splicing leads to cellular upregulation of ribosomal proteins (RPs), less proliferative signals and abnormal lipid accumulation. Knockout of SFs leads to failure of liver regeneration and zonal disorder. SF reduction marks severe MASLD in patients and knockout mouse models. Our results lay the molecular foundation for tissue repair initiation and further developing potential therapeutic target for liver disease.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101654"},"PeriodicalIF":7.1000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and Molecular Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcmgh.2025.101654","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Tissue injury with regenerative obstacle leads to liver failure and inevitable consequent hepatic diseases. Yet, precise spatial and molecular alterations to initiate liver regeneration remains unknown.

Methods: We employ spatiotemporal sequencing of regenerating liver combined with high-throughput single-cell RNA sequencing of established hepatocyte organoids (Hep-Orgs) mimicking the regenerative start, elucidate that splicing factors (SFs) were key factors responsible for liver regeneration. Additionally, we verify the function of splicing factors in knockout mice models in vivo.

Results: We observed that the up-regulation of SFs in regenerative zone of liver and pre-cycling or cycling hepatocytes subpopulation of Hep-Orgs. We demonstrated that the splicing inhibitors suppress liver regeneration by increasing ribosomal proteins. Moreover, we identified Hnrnpu as the key SF for liver regeneration benefit to preventing chronic liver disease like metabolic dysfunction-associated steatotic liver disease (MASLD) CONCLUSIONS: The spatial remodeling of upregulated RNA splicing factors drives the first regenerative wave from the periportal zone. The reprogrammed subpopulations defined by highly expressed SFs represent original repopulating hepatocytes. Inhibiting RNA splicing leads to cellular upregulation of ribosomal proteins (RPs), less proliferative signals and abnormal lipid accumulation. Knockout of SFs leads to failure of liver regeneration and zonal disorder. SF reduction marks severe MASLD in patients and knockout mouse models. Our results lay the molecular foundation for tissue repair initiation and further developing potential therapeutic target for liver disease.

RNA剪接因子的激活和空间再分配触发肝脏再生。
背景与目的:组织损伤伴再生障碍导致肝功能衰竭和不可避免的肝脏疾病。然而,启动肝脏再生的精确空间和分子改变仍然未知。方法:采用再生肝脏的时空测序结合高通量单细胞RNA测序,对已建立的模拟再生开始的肝细胞类器官(Hep-Orgs)进行测序,阐明剪接因子(SFs)是肝脏再生的关键因素。此外,我们在敲除小鼠体内模型中验证了剪接因子的功能。结果:我们观察到肝脏再生区和Hep-Orgs的预循环或循环肝细胞亚群中SFs的上调。我们证明剪接抑制剂通过增加核糖体蛋白来抑制肝脏再生。此外,我们发现Hnrnpu是肝再生的关键SF,可以预防慢性肝脏疾病,如代谢功能障碍相关的脂肪变性肝病(MASLD)。结论:上调RNA剪接因子的空间重塑驱动第一个再生波来自门静脉周围区。由高表达的SFs定义的重编程亚群代表原始的重新填充的肝细胞。抑制RNA剪接导致细胞核糖体蛋白(RPs)上调,增殖信号减少和异常脂质积累。敲除SFs导致肝脏再生失败和区域性疾病。SF减少标志着患者和敲除小鼠模型严重的MASLD。我们的研究结果为肝脏疾病组织修复启动和进一步开发潜在治疗靶点奠定了分子基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.00
自引率
2.80%
发文量
246
审稿时长
42 days
期刊介绍: "Cell and Molecular Gastroenterology and Hepatology (CMGH)" is a journal dedicated to advancing the understanding of digestive biology through impactful research that spans the spectrum of normal gastrointestinal, hepatic, and pancreatic functions, as well as their pathologies. The journal's mission is to publish high-quality, hypothesis-driven studies that offer mechanistic novelty and are methodologically robust, covering a wide range of themes in gastroenterology, hepatology, and pancreatology. CMGH reports on the latest scientific advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology related to gastrointestinal, hepatobiliary, and pancreatic health and disease. The research published in CMGH is designed to address significant questions in the field, utilizing a variety of experimental approaches, including in vitro models, patient-derived tissues or cells, and animal models. This multifaceted approach enables the journal to contribute to both fundamental discoveries and their translation into clinical applications, ultimately aiming to improve patient care and treatment outcomes in digestive health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信